Hyewon Kim

Hyewon Kim

Auto-generated profile, based on publicly available information

Hyewon Kim

Department of Psychiatry, College of Medicine, Hallym University, Hallym University Sacred Heart Hospital

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2021 in Psychiatry Investigation
Verified
Journal Article
Open access
PDF file
MPMi Jin Park
Mi Jin Park
HKHyewon Kim
Hyewon Kim
EKEun Ji Kim
Eun Ji Kim
VYVidal Yook
Vidal Yook
ICIn Won Chung
In Won Chung
HJHong Jin Jeon
Hong Jin Jeon
Objective Electro-convulsive therapy (ECT) has been established as a treatment modality for patients with treatment-resistant depression and with some specific subtypes of depression. This narrative review intends to provide psychiatrists with the latest findings on the use of ECT in depression, devided into total eight sub-topics.Methods We searched PubMed for English-language articles using combined keywords and tried to analyze journals published from 1995–2020.Results Pharmacotherapy such as antidepressants or maintenance ECT is more effective than a placebo as prevention of recurrence after ECT. The use of ECT in treatment-resistant depression, depressed patients with suicidal risks, elderly depression, bipolar depression, psychotic depression, and depression during pregnancy or postpartum have therapeutic benefits. As possible mechanisms of ECT, the role of neurotransmitters such as serotonin, dopamine, gamma-aminobutyric acid (GABA), and other findings in the field of neurophysiology, neuro-immunology, and neurogenesis are also supported.Conclusion ECT is evolving toward reducing cognitive side effects and maximizing therapeutic effects. If robust evidence for ECT through randomized controlled studies are more established and the mechanism of ECT gets further clarified, the scope of its use in the treatment of depression will be more expanded in the future.

19 February 2023 in Journal of Affective Disorders
Verified
Journal Article
Closed access
HKHyewon Kim
Hyewon Kim
SRSoorack Ryu
Soorack Ryu
HJHong Jin Jeon
Hong Jin Jeon
SRSungwon Roh
Sungwon Roh

1 November 2021 in Journal of Affective Disorders
Verified
Journal Article
Closed access
JBJi Hyun Baek
Ji Hyun Baek
DSDong Wook Shin
Dong Wook Shin
MFMaurizio Fava
Maurizio Fava
DMDavid Mischoulon
David Mischoulon
HKHyewon Kim
Hyewon Kim
HJHong Jin Jeon
Hong Jin Jeon

25 January 2021 in Psychiatry Investigation
Verified
Journal Article
Open access
PDF file
HKHyewon Kim
Hyewon Kim
YKYuwon Kim
Yuwon Kim
MSMyung-Hee Shin
Myung-Hee Shin
KCKwan Woo Choi
Kwan Woo Choi
MCManki Chung
Manki Chung
HJHong Jin Jeon
Hong Jin Jeon
Objective To investigate the association between thyroidectomy and suicide attempt. Methods A nationwide population based electronic medical records database of South Korea between January 1, 2009 and June 30, 2016 was used to investigate incidence rate ratios (IRRs) of suicide attempts and probable suicide attempts before and after thyroidectomy using a self-controlled case series design. Results In 2,986 patients who attempted suicide or probable suicide, the IRRs of suicidal behaviors during risk periods one year before and after thyroidectomy were investigated. Generally, after thyroidectomy, there was no increase in IRR compared to the non-risk period. When data were analyzed according to thyroidectomy type, after partial thyroidectomy, IRR increased up to 1.43 (95% CI: 1.03-1.98, p=0.032) in the days 91-181 period. In the subgroup with major depressive disorder (MOD), the IRR increased up to 1.74 (95% CI: 1.21-2.51, p=0.003) before thyroidectomy, and increased up to 1.67 (95% CI: 1.16-2.41, p=0.006) after thyroidectomy. Conclusion Although the general risk of suicide attempt was not increased after thyroidectomy, patients with MDD showed increased risk of suicide attempt before and after thyroidectomy. These results suggest that suicidality should be evaluated when depressive symp- toms are present in patients who have undergone thyroidectomy.

20 June 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SSSisu Seong
Sisu Seong
HKHyewon Kim
Hyewon Kim
YCYaehee Cho
Yaehee Cho
MKMin-Ji Kim
Min-Ji Kim
KPKa Ram Park
Ka Ram Park
HJHong Jin Jeon
Hong Jin Jeon
Background: Use of virtual reality (VR)–based biofeedback (BF) represents an emerging nonpharmacological intervention for enhancing sleep quality in individuals exhibiting depressive symptoms, anxiety symptoms, or both. However, empirical evidence regarding its efficacy in addressing sleep disturbances remains limited and inconclusive. Objective: This 3-arm randomized controlled trial aimed (1) to compare the efficacy of VR-based BF with conventional BF in improving sleep quality, as measured by the Pittsburgh Sleep Quality Index (PSQI), among individuals with depressive symptoms, anxiety symptoms, or both (DAS); (2) to examine the effects of VR-based BF in a demographically similar healthy control (HC) group; and (3) to evaluate between-group differences in sleep quality improvements at the 4-week follow-up. Methods: Participants scoring ≥10 on the Patient Health Questionnaire-9 or ≥9 on the Panic Disorder Severity Scale were allocated to a group with DAS while others were assigned to a HC group. The DAS group was subsequently randomized into VR-based BF or conventional BF interventions with a therapist. All participants attended sessions at weeks 0, 2, and 4, completing assessments including the Montgomery-Asberg Depression Rating Scale, State-Trait Anxiety Inventory, and Visual Analog Scale in interviews. The PSQI was administered at baseline and postintervention to evaluate alterations in sleep quality over a 4-week period. Results: A total of 118 participants were randomized into a VR-based BF group (DAS/VR, n=40) or a conventional BF group (DAS/BF, n=38), and a control group (HC/VR, n=40) received VR-based BF. Sleep disturbance scores of both DAS/VR and DAS/BF groups had significant improvements (mean reductions of −0.58, SD 0.75 and −0.66, SD 0.75, respectively) compared to those preintervention, showing no significant difference after adjusting for age and sex (P=.49). The DAS/VR group had a greater improvement in sleep disturbance (mean −0.08, SD 0.53; P=0.0014) than the HC/VR group. Global PSQI scores in both DAS/VR and DAS/BF groups improved compared to those preintervention, showing decreases by −2.50 (SD 2.89) and −3.39 (SD 2.80), respectively. The difference between the 2 groups was not statistically significant (P=.14). The Global PSQI score in the DAS/VR group showed significant improvement (−0.95, SD 2.09; P=.01) compared to that in the HC/VR group. Conclusions: This study provides evidence that both VR-based BF and conventional BF with a therapist are efficacious psychological interventions for enhancing sleep quality in individuals with depressive symptoms, anxiety symptoms, or both, with no significant differences observed between these 2 approaches. Both interventions showed significant improvements compared to baseline measurements. These findings suggest potential applications of these interventions in clinical settings to improve sleep quality and mental well-being.

28 February 2019 in Korean Journal of Youth Studies
Verified
Journal Article
Closed access
HKHyewon Kim
Hyewon Kim
HCHyunjoo Cho
Hyunjoo Cho
EHEunyoung Hong
Eunyoung Hong
본 연구는 청소년의 위험 환경 요인과 자살위험성과의 관계에서 외현적 공격성의 매개효과를 검증하기 위한 목적으로 진행되었다. C시에 소재하는 12개교 중·고등학교 학생과 학교이외에 소속되어 있는 학교 밖 청소년 전체 800명을 대상으로 자기보고식 설문지 조사를 하였다. 최종적으로 743부를 사용하여 상관분석과 위계적 중다 회귀분석을 실시하였다. 연구결과 첫째, 가정위험, 학교위험, 자살위험성과 외현적 공격성 사이에 모두 정적상관관계를 보였다. 둘째, 가정과 학교 위험요인과 자살위험성의 관계에서 외현적 공격성은 모두 부분 매개하였다. 이와 같은 연구결과를 바탕으로 가정과 학교 위험 요인, 자살취약성 및 외현적 공격성에 대한 실천적 함의를 제언하였다.